We achieve this through the pragmatic application of scientific excellence in Pharmaceutical Technology and Clinical Pharmacology. Our ambition is to provide our Clients with the experience and level of expertise that may be found in the development functions of major pharmaceutical companies but with the speed and flexibility required in the fast moving biotech sector.
Our knowledge and experience allow us to quickly identify the essential experiments for the phase of development and deliver a suitable data package to meet the regulatory expectations whilst ensuring that the clinical programme has the best chance of success. Equally important is our ability to identify work that can be delayed until after the next value inflection point to ensure that the spend profile is managed appropriately.
We understand that speed is of the essence, particularly in early stages of development, and we ensure that our systems and process have the agility to stay off the critical path.
We know that if we can contribute to the value proposition of our Clients, we will play our part in bringing new, innovative therapies to patients.
Explore our services
Our team of experts have many decades of experience in all stages of Pharmaceutical Development, DMPK and Clinical Pharmacology and the associated regulatory requirements and are on hand to guide the CMC and PK aspects of your development programme.
SEDA has state-of-the-art laboratory capabilities for the rapid screening, testing and development of conventional and novel formulations to give your compound the best chance of success. We also specialise in the development of clinically relevant dissolution methods for late phase development / registration.
SEDA’s modelling team and our proprietary & commercial software are perfectly placed to support translation of preclinical data to the clinical setting and onwards selection & justification of the go forward dose.